India  
 
NewsR.in

Promising data in U.S. AstraZeneca vaccine trials, 100% effective vs. severe or critical disease

Video Credit: 23ABC News | Bakersfield - Duration: 02:05s - Published
Promising data in U.S. AstraZeneca vaccine trials, 100% effective vs. severe or critical disease

Promising data in U.S. AstraZeneca vaccine trials, 100% effective vs. severe or critical disease

The much-anticipated trial data for a fourth vaccine here in the u-s is out and looking promising.

Officials are wondering when AstraZeneca might be added to the covid vaccine arsenal that includes Pfizer, Moderna, and Johnson & Johnson.

This as officials try to crack down on spring breakers partying which experts say is leading to a surge in new cases.

ABC's Reena Roy has the latest.


You Might Like


Related videos from verified sources

Children's Hospital data show Pfizer's COVID vaccine 100% effective in kids age 12-15 [Video]

Children's Hospital data show Pfizer's COVID vaccine 100% effective in kids age 12-15

A study released Wednesday by Pfizer suggests that its COVID-19 vaccine was 100% effective in preventing coronavirus infection in children ages 12 to 15.

Credit: WCPO Cincinnati     Duration: 02:33Published
Dr. Hotez on Pfizer report finding: It's pretty impressive [Video]

Dr. Hotez on Pfizer report finding: It's pretty impressive

Dr.Ā Peter Hotez,Ā co-director of Texas Childrenā€™s Hospitalā€™sĀ CenterĀ for VaccineĀ Development says the the clinical trial results of Pfizer/BioNTechā€™s Covid-19 vaccine showing 100% efficacy in..

Credit: Bleacher Report AOL     Duration: 02:01Published
IU School of Medicine lead researcher, participants on AstraZeneca trial [Video]

IU School of Medicine lead researcher, participants on AstraZeneca trial

Nationwide there were 88 trials of the vaccine. One happening at the IU School of Medicine with 530 participants.

Credit: RTV6 The Indy Channel     Duration: 04:06Published